Diagnostics
We leverage our core expertise in the molecular mechanisms of different ophthalmic disorders for innovative diagnostic and therapeutic development.
We leverage our core expertise in the molecular mechanisms of different ophthalmic disorders for innovative diagnostic and therapeutic development.
Seinda’s proprietary i-ImmunDx™ platform is specifically designed for ophthalmic point-of-care applications. The i-ImmunDx™ platform is the basis for the development of Seinda’s series of point-of-care testing (POCT) products. Our line of POCT products help facilitate clinical diagnosis, aid treatment selection, and monitor disease status.
Our team possesses expertise in immunology, cell biology, systems biology, and bioinformatics. We specialize in the study of disease mechanisms and excel in multi-omics analysis of clinical microsamples. Our proficiency spans basic ophthalmology research, biomarker investigation across various diseases, bioinformatics, clinical research, and the conduct of clinical drug trials.